![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2018
Salaga, Maciej; Binienda, Agata; Tichkule, Ritesh B.; Thakur, Ganesh A.; Makriyannis, Alexandros; Storr, Martin und Fichna, Jakub
(2018):
The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.
In: European Journal of Pharmacology, Bd. 836: S. 34-43
Binienda, Agata; Storr, Martin; Fichna, Jakub und Salaga, Maciej
(2018):
Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review.
In: Current Drug Targets, Bd. 19, Nr. 15: S. 1774-1781
2016
Salaga, Maciej; Storr, Martin; Martemyanov, Kirill A. und Fichna, Jakub
(2016):
akademischenFestredenEmilDuBois-Reymonds(1818–1896).
In: Bioessays, Bd. 38, Nr. 4: S. 344-354
Zielińska, Marta; Jarmuż, Agata; Salaga, Maciej; Kordek, Radzislaw; Laudon, Moshe; Storr, Martin und Fichna, Jakub
(2016):
Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.
In: Naunyn-Schmiedebergs Archives of Pharmacology, Bd. 389, Nr. 5: S. 511-519